Abklärung erhöhter Leberwerte

Literatur
1 American Thoracic Society/European Respiratory Society Statement. Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900
2 Bahr MJ. Nichtinvasive Leberfibrosebestimmung. Med Welt 2009; 60: 137-142
3 Bahr MJ. Vascular liver disease. In: Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, eds. Hepatology – A clinical textbook. 3rd. ed. Düsseldorf: Flying Publisher; 2012: 509-525
4 Bahr MJ, Bantel H, Lichtinghagen R. Labordiagnostik. In: Bahr MJ, ed. Nichtinvasive Diagnostik bei Lebererkrankungen. Bremen: UNI-MED Verlag; 2011: 15-29
5 Bahr MJ, Rifai K, Bantel H. Verhalten bei erhöhten Leberwerten. In: Bahr MJ, ed. Nichtinvasive Diagnostik bei Lebererkrankungen. Bremen: UNI-MED Verlag; 2011: 45-57
6 Benckert J, Berg T. Diagnostik und Klinik der Infektion mit Hepatitis-A- und Hepatitis-E-Viren. Pharm Unserer Zeit 2011; 40: 25-29
7 Chapman R, Fevery J, Kalloo A et al. AASLD Practice Guidelines. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-671
8 Cornberg M, Protzer U, Petersen J et al. Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. Z Gastroenterol 2011; 49: 871-930
9 Dalton HR, Bendall R, Ijaz S et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709
10 Dufour DR, Lott JA, Nolte FS et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46: 2050-2068
11 EASL Clinical Practice Guidelines. HFE hemochromatosis. J Hepatol 2010; 53: 3-22
12 Hadem J, Strassburg CP, Manns MP. Prediction of outcome and selection of the liver transplantat candidate in acute liver failure. Frontiers Physiol 2012; 3: 1-7
13 Hennes EM, Zeniya M, Czaja AJ et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176
14 Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011; 378: 73-85
15 Kim WR, Flamm SL, Di Bisceglie AM et al. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008; 47: 1363-1370
16 Lazo M, Selvin E, Clark JM. Clinical implications of short-term variability in liver function test results. Ann Intern Med 2008; 148: 348-352
17 Lindor KD, Gershwin ME, Poupon R et al. AASLD Practice Guidelines. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308
18 Manns MP, Czaja AJ, Gorham JD et al. AASLD Practice Guidelines. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213
19 Moss DW. Diagnostic aspects of alkaline phosphatase and its isoenzymes. Clin Biochem 1987; 20: 225-230
20 O’Shea RS, Dasarathy S, McCullough AJ et al. AASLD Practice Guidelines. Alcoholic liver disease. Hepatology 2010; 51: 307-328
21 Roberts EA, Schilsky ML. AASLD Practice Guidelines. Diagnosis and treatment of Wilson disease. Hepatology 2008; 47: 2089-2111
22 Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725
23 Sarrazin C, Berg T, Ross RS et al. Update der S3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion. Z Gastroenterol 2010; 48: 289-351
24 Schirmacher P, Fleig WE, Tannapfel A et al. Bioptische Diagnostik der chronischen Hepatitis. Pathologe 2004; 25: 337-348
25 Swain MG. Fatigue in liver disease: Pathophysiology and clinical management. Can J Gastroenterol 2006; 20: 181-188
26 Vavricka SR, Burri E, Beglinger C et al. Serum protein electrophoresis: an underused but very useful test. Digestion 2009; 79: 203-210
27 Vergani D, Alvarez F, Bianchi FB et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41: 677-683
28 Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355